4/A//SEC Filing
Meyers Michael L. 4/A
Accession 0001562180-19-002023
CIK 0001395937other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:03 PM ET
Size
5.0 KB
Accession
0001562180-19-002023
Insider Transaction Report
Form 4/AAmended
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Purchase
Common Stock
2019-03-21$4.87/sh+8$39→ 7,230 total
Footnotes (1)
- [F1]Amendment filed to correct previously filed Form, which did not include 8 shares purchased in an additional transaction.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001664204
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:03 PM ET
- Size
- 5.0 KB